Bicara Therapeutics Inc. ... (BCAX)
11.83
-1.43 (-10.78%)
At close: Apr 03, 2025, 3:59 PM
11.69
-1.18%
Pre-market: Apr 04, 2025, 04:26 AM EDT
Bicara Therapeutics Common Stock Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
35
Upside
195.86
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Cantor Fitzgerald | Buy | Initiates | 14 14 | 9.97% | Mar 13, 2025 | |
| Wedbush | Buy | Initiates | 31 31 | 162.05% | Feb 12, 2025 | |
| Wedbush | Buy | Initiates | 31 | 162.05% | Feb 6, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.